Publicaciones en colaboración con investigadoras/es de Università degli Studi di Brescia (16)

2024

  1. Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry

    Seminars in Arthritis and Rheumatism, Vol. 66

  2. Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository (“Registry”)

    Seminars in Arthritis and Rheumatism, Vol. 65

2023

  1. Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository

    Arthritis and Rheumatology, Vol. 75, Núm. 8, pp. 1407-1414

  2. Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study

    Laboratory investigation; a journal of technical methods and pathology, Vol. 103, Núm. 6, pp. 100147

  3. Fluctuation of Anti–Domain 1 and Anti–β2-Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies

    Arthritis and Rheumatology, Vol. 75, Núm. 6, pp. 984-995

  4. Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases

    The Lancet Rheumatology

2020

  1. Comparative study between two european inception cohorts of patients with early systemic lupus erythematosus

    Clinical and Experimental Rheumatology, Vol. 38, Núm. 5, pp. 925-932

2019

  1. A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires

    Clinical Pharmacology and Therapeutics, Vol. 106, Núm. 2, pp. 374-382

  2. EULAR recommendations for the management of antiphospholipid syndrome in adults

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 10, pp. 1296-1304

2018

  1. A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires

    Clinical Pharmacology and Therapeutics, Vol. 103, Núm. 6, pp. 1074-1082

2016

  1. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 5, pp. 795-810

  2. The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies: Evidence and clinical judgment

    Thrombosis and Haemostasis, Vol. 115, Núm. 2, pp. 285-290

2015

  1. State of the art: Reproduction and pregnancy in rheumatic diseases

    Autoimmunity Reviews, Vol. 14, Núm. 5, pp. 376-386

2012

  1. High intensity anticoagulation in the prevention of the recurrence of arterial thrombosis in antiphospholipid syndrome: 'PROS' and 'CONS'

    Autoimmunity Reviews, Vol. 11, Núm. 8, pp. 577-580

2011

  1. Pregnancy and reproduction in autoimmune rheumatic diseases

    Rheumatology, Vol. 50, Núm. 4, pp. 657-664

2006

  1. Anti-inflammatory and immunosuppressive drugs and reproduction

    Arthritis Research and Therapy, Vol. 8, Núm. 3